{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:42:40Z","timestamp":1793241760186,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.bioactmat.2021.10.039","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T02:04:38Z","timestamp":1635818678000},"page":"286-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Lipoprotein-biomimetic nanostructure enables tumor-targeted penetration delivery for enhanced photo-gene therapy towards glioma"],"prefix":"10.1016","volume":"13","author":[{"given":"Ruoning","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junsong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuqing","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7466-9602","authenticated-orcid":false,"given":"Yang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl_4","key":"10.1016\/j.bioactmat.2021.10.039_bib1","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro Oncol."},{"issue":"4","key":"10.1016\/j.bioactmat.2021.10.039_bib2","first-page":"299","article-title":"Management of glioblastoma: state of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioactmat.2021.10.039_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","article-title":"The blood-brain barrier: physiology and strategies for drug delivery","volume":"165\u2013166","author":"Pandit","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.bioactmat.2021.10.039_bib4","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and dysfunction of the blood-brain barrier","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bioactmat.2021.10.039_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","article-title":"The blood-brain barrier and blood-tumour barrier in brain tumours and metastases","volume":"20","author":"Arvanitis","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.bioactmat.2021.10.039_bib6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/neuonc\/nox175","article-title":"Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data","volume":"20","author":"Sarkaria","year":"2018","journal-title":"Neuro Oncol."},{"issue":"9","key":"10.1016\/j.bioactmat.2021.10.039_bib7","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1021\/acs.nanolett.8b01879","article-title":"Peptide-functionalized nanoinhibitor restrains brain tumor growth by abrogating mesenchymal-epithelial transition factor (MET) signaling","volume":"18","author":"Wu","year":"2018","journal-title":"Nano Lett."},{"issue":"7","key":"10.1016\/j.bioactmat.2021.10.039_bib8","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1039\/C8CS00618K","article-title":"Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer","volume":"48","author":"Liu","year":"2019","journal-title":"Chem. Soc. Rev."},{"issue":"4","key":"10.1016\/j.bioactmat.2021.10.039_bib9","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1021\/cr5004198","article-title":"Nanoparticles in photodynamic therapy","volume":"115","author":"Lucky","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioactmat.2021.10.039_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119827","article-title":"Advances in nanomaterials for photodynamic therapy applications: status and challenges","volume":"237","author":"Chen","year":"2020","journal-title":"Biomaterials"},{"issue":"43","key":"10.1016\/j.bioactmat.2021.10.039_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201704196","article-title":"Structure-guided design and synthesis of a mitochondria-targeting near-infrared fluorophore with multimodal therapeutic activities","volume":"29","author":"Tan","year":"2017","journal-title":"Adv. Mater."},{"issue":"22","key":"10.1016\/j.bioactmat.2021.10.039_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202001862","article-title":"A Porous Au@Rh bimetallic core-shell nanostructure as an H2O2-driven oxygenerator to alleviate tumor hypoxia for simultaneous bimodal imaging and enhanced photodynamic therapy","volume":"32","author":"Wang","year":"2020","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.bioactmat.2021.10.039_bib13","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/s41467-020-15591-4","article-title":"An open source and reduce expenditure ROS generation strategy for chemodynamic\/photodynamic synergistic therapy","volume":"11","author":"Liu","year":"2020","journal-title":"Nat. Commun."},{"issue":"35","key":"10.1016\/j.bioactmat.2021.10.039_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201802006","article-title":"Aggressive man-made red blood cells for hypoxia-resistant photodynamic therapy","volume":"30","author":"Liu","year":"2018","journal-title":"Adv. Mater."},{"issue":"7","key":"10.1016\/j.bioactmat.2021.10.039_bib15","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1021\/acs.nanolett.9b00934","article-title":"Biomimetic hybrid nanozymes with self-supplied H+ and accelerated O2 generation for enhanced starvation and photodynamic therapy against hypoxic tumors","volume":"19","author":"Yang","year":"2019","journal-title":"Nano Lett."},{"issue":"6","key":"10.1016\/j.bioactmat.2021.10.039_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrc3064","article-title":"Targeting hypoxia in cancer therapy","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.bioactmat.2021.10.039_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","article-title":"Exploiting tumour hypoxia in cancer treatment","volume":"4","author":"Brown","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bioactmat.2021.10.039_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia-a key regulatory factor in tumour growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.bioactmat.2021.10.039_bib19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.bioactmat.2021.10.039_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","article-title":"Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy","volume":"33","author":"Semenza","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.bioactmat.2021.10.039_bib21","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1021\/nn405773r","article-title":"Multifunctional albumin-MnO2 nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response","volume":"8","author":"Prasad","year":"2014","journal-title":"ACS Nano"},{"issue":"24","key":"10.1016\/j.bioactmat.2021.10.039_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202000416","article-title":"Single siRNA nanocapsules for effective siRNA brain delivery and glioblastoma treatment","volume":"32","author":"Zou","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2021.10.039_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119742","article-title":"Targeting the undruggable in pancreatic cancer using nano-based gene silencing drugs","volume":"240","author":"Kokkinos","year":"2020","journal-title":"Biomaterials"},{"issue":"49","key":"10.1016\/j.bioactmat.2021.10.039_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201903637","article-title":"Rekindling RNAi therapy: materials design requirements for in vivo siRNA delivery","volume":"31","author":"Kim","year":"2019","journal-title":"Adv. Mater."},{"issue":"43","key":"10.1016\/j.bioactmat.2021.10.039_bib25","doi-asserted-by":"crossref","first-page":"12743","DOI":"10.1002\/anie.201504661","article-title":"Switchable lipids: conformational change for fast pH-triggered cytoplasmic delivery","volume":"54","author":"Viricel","year":"2015","journal-title":"Angew. Chem. Int. Ed Engl."},{"issue":"6","key":"10.1016\/j.bioactmat.2021.10.039_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aar8409","article-title":"Endothelial siRNA delivery in nonhuman primates ysing ionizable low-molecular weight polymeric nanoparticles","volume":"4","author":"Khan","year":"2018","journal-title":"Sci. Adv."},{"issue":"26","key":"10.1016\/j.bioactmat.2021.10.039_bib27","doi-asserted-by":"crossref","first-page":"7492","DOI":"10.1002\/anie.201601441","article-title":"In situ functionalized polymers for siRNA delivery","volume":"55","author":"Priegue","year":"2016","journal-title":"Angew. Chem. Int. Ed Engl."},{"issue":"7","key":"10.1016\/j.bioactmat.2021.10.039_bib28","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1021\/jacs.8b12501","article-title":"Transferrin-appended nanocaplet for transcellular siRNA delivery into deep tissues","volume":"141","author":"Kohata","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"14","key":"10.1016\/j.bioactmat.2021.10.039_bib29","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1002\/anie.201510844","article-title":"Biodegradable inorganic nanovector: passive versus active tumor targeting in siRNA transportation","volume":"55","author":"Park","year":"2016","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"3","key":"10.1016\/j.bioactmat.2021.10.039_bib30","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1021\/acsnano.6b07195","article-title":"Multifunctional envelope-type siRNA delivery nanoparticle platform for prostate cancer therapy","volume":"11","author":"Xu","year":"2017","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.bioactmat.2021.10.039_bib31","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1021\/acsnano.9b00661","article-title":"Ligand-modified cell membrane enables the targeted delivery of drug nanocrystals to glioma","volume":"13","author":"Chai","year":"2019","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.bioactmat.2021.10.039_bib32","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1021\/acs.nanolett.9b04683","article-title":"Charge conversional biomimetic nanocomplexes as a multifunctional platform for boosting orthotopic glioblastoma RNAi therapy","volume":"20","author":"Liu","year":"2020","journal-title":"Nano Lett."},{"issue":"6","key":"10.1016\/j.bioactmat.2021.10.039_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201801899","article-title":"Embryonic stem cells-derived exosomes endowed with targeting properties as chemotherapeutics delivery vehicles for glioblastoma therapy","volume":"6","author":"Zhu","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioactmat.2021.10.039_bib34","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.biomaterials.2018.06.029","article-title":"NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo","volume":"178","author":"Jia","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2021.10.039_bib35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.addr.2020.08.003","article-title":"Lipoprotein-based drug delivery","volume":"159","author":"Busatto","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.bioactmat.2021.10.039_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1021\/acs.accounts.7b00339","article-title":"High-density lipoprotein nanobiologics for precision medicine","volume":"51","author":"Mulder","year":"2018","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bioactmat.2021.10.039_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119413","article-title":"Laser-triggered polymeric lipoproteins for precision tumor penetrating theranostics","volume":"221","author":"Wang","year":"2019","journal-title":"Biomaterials"},{"issue":"33","key":"10.1016\/j.bioactmat.2021.10.039_bib38","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1038\/onc.2011.537","article-title":"Transtumoral targeting enabled by a novel neuropilin-binding peptide","volume":"31","author":"Roth","year":"2012","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.bioactmat.2021.10.039_bib39","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1021\/acs.nanolett.7b05087","article-title":"Peptide-functionalized phase-transformation nanoparticles for low intensity focused ultrasound-assisted tumor imaging and therapy","volume":"18","author":"Zhu","year":"2018","journal-title":"Nano Lett."},{"issue":"7","key":"10.1016\/j.bioactmat.2021.10.039_bib40","doi-asserted-by":"crossref","first-page":"7201","DOI":"10.1021\/acsnano.7b03088","article-title":"Stimuli-responsive \"cluster bomb\" for programmed tumor therapy","volume":"11","author":"Lei","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2021.10.039_bib41","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1038\/ncomms5904","article-title":"An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability","volume":"5","author":"Pang","year":"2014","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bioactmat.2021.10.039_bib42","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/anie.201810541","article-title":"A water-soluble, NIR-absorbing quaterrylenediimide chromophore for photoacoustic imaging and efficient photothermal cancer therapy","volume":"58","author":"Liu","year":"2019","journal-title":"Angew. Chem. Int. Ed Engl."},{"issue":"9","key":"10.1016\/j.bioactmat.2021.10.039_bib43","doi-asserted-by":"crossref","first-page":"9536","DOI":"10.1021\/acsnano.7b05465","article-title":"Molecular-targeted immunotherapeutic strategy for melanoma via dual-targeting nanoparticles delivering small interfering RNA to tumor-associated macrophages","volume":"11","author":"Qian","year":"2017","journal-title":"ACS Nano"}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X21005041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X21005041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:59:24Z","timestamp":1762531164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X21005041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":43,"alternative-id":["S2452199X21005041"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2021.10.039","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein-biomimetic nanostructure enables tumor-targeted penetration delivery for enhanced photo-gene therapy towards glioma","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2021.10.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}